{"name":"James Murrough","slug":"james-murrough","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNSTZRbDdkc3p0ZUl2YWNpem1HUjhLUnl0MHNrM1E0QzJkbUgtN3FLUU1xQTRfMDlubmRfWEt4ajIwNm55MlFJbDY3Nkh1UC1VZ1NweUNUSzkxdVhtcDhRZlBrRHFiVTVmREZ3RjFqSWdoZk9xa0VHcUV4NEVXcXJOSU4zTFA0QlVHOERIYTF5SVpodlpWaXcwSDZIRWM3SkNKbUIwTE5kajIwUUltemFrNGVWelM1YzlNOUE?oc=5","date":"2023-11-04","type":"pipeline","source":"Fortune","summary":"Ketamine has been called a breakthrough therapy for depression, but it comes with risks. Here's how it works - Fortune","headline":"Ketamine has been called a breakthrough therapy for depression, but it comes with risks. Here's how it works","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE8tUVJsR3lWV0N6OGR5NXFwWTVxZFRrZGtGSkRYNFB3Qkw5TVJFZUJYY29xbUdwak9PaHptOUJRTzdMN1htOW9LYnhSU2FITEdIN2dhdFNsdFJtWi1kc1RjcGh6Q0F2blp1RHFHZQ?oc=5","date":"2019-07-18","type":"pipeline","source":"Psychiatry Online","summary":"Psychopharmacology and Experimental Therapeutics for Bipolar Depression - Psychiatry Online","headline":"Psychopharmacology and Experimental Therapeutics for Bipolar Depression","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQZnR2ZGpqd1FhUFFEdDlldUNGUVpYQ0stb2dyem1yOFFENEF6bThvdUs3YzlMcnNBUE9kb0FVVzRGUGRnLXdaX0x2dUd5U2ZTWVdRNjJGOGswMnpCazVPdnJBNWRLT0NTTEE5WExaOVh4UmN3aFo1aG52a2pZNjNOZ2NHTEZlWnB4OFNFOUtnRlR0Q2l2LWRKQm1iaGctbDRy?oc=5","date":"2018-10-19","type":"pipeline","source":"Scientific American","summary":"In an Old Drug, New Hope for Depression - Scientific American","headline":"In an Old Drug, New Hope for Depression","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQUWUzSm01Nkcta245bHFRU1ktcFphZDcwRkY5MUgzN3M4V200cWJpV1RHY0UwMF9uYXZRZzFPMkM1Yi1mMjRHM2ZHbV9faFRSYUx6MmlkY1FlRzZSRGRxOG50VGdFLTRaeUpUNXVsYW9kOEJOODJWMFBfeVBHLTNUMlJLU1llNkhSdlJnU3kyakszN2l4ZzJ2LUlGbw?oc=5","date":"2015-01-08","type":"pipeline","source":"Salon.com","summary":"Pharma companies make moves to cash in on party drug ketamine - Salon.com","headline":"Pharma companies make moves to cash in on party drug ketamine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQa0EwQ01mT1VqMlRKOGFXMTA0SlEteEVHR0g3d2Q4eEZEcHZ1bjlxZUpWLUZtSlRkOHBXdGxQUFl1alhtZzhJREJ4bHBRQ1BkRkE2NXVOQkV6RFJPT1FPV3N0N2VrbjNnR24wSEJmRGNXOHFoSDEtczhBa2RMeV9FWktWVzlmYUQtV1BF?oc=5","date":"2013-10-16","type":"pipeline","source":"The Verge","summary":"Not-so special K: Big Pharma wants ketamine clones to treat depression - The Verge","headline":"Not-so special K: Big Pharma wants ketamine clones to treat depression","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}